AMRN Q1 2024 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$57M-34.3% YoY

Gross Profit

$32M56.4% margin

Operating Income

-$14M-24.0% margin

Net Income

-$10M-17.6% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

-25.0%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$790M

Total Liabilities

$244M

Stockholders' Equity

$546M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$86M	-34.3%
Gross Profit	$32M	$48M	-33.4%
Operating Income	-$14M	-$17M	+21.7%
Net Income	-$10M	-$16M	+39.5%

Revenue Segments

Product

$55M98%

Licensing And Royalty

$1M2%